GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Gross Margin %

Aelis Farma (XPAR:AELIS) Gross Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Aelis Farma's Gross Profit for the six months ended in Dec. 2023 was €5.32 Mil. Aelis Farma's Revenue for the six months ended in Dec. 2023 was €5.32 Mil. Therefore, Aelis Farma's Gross Margin % for the quarter that ended in Dec. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Aelis Farma's Gross Margin % or its related term are showing as below:


XPAR:AELIS's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.9
* Ranked among companies with meaningful Gross Margin % only.

Aelis Farma had a gross margin of N/A% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Aelis Farma was 0.00% per year.


Aelis Farma Gross Margin % Historical Data

The historical data trend for Aelis Farma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Gross Margin % Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial - - - - -

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aelis Farma's Gross Margin %

For the Biotechnology subindustry, Aelis Farma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aelis Farma's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Gross Margin % falls into.



Aelis Farma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Aelis Farma's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=9.1 / 9.054
=(Revenue - Cost of Goods Sold) / Revenue
=(9.054 - 0) / 9.054
=N/A %

Aelis Farma's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=5.3 / 5.32
=(Revenue - Cost of Goods Sold) / Revenue
=(5.32 - 0) / 5.32
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Aelis Farma  (XPAR:AELIS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Aelis Farma had a gross margin of N/A% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Aelis Farma Gross Margin % Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines